Supriya Lifescience Ltd

NSE: SUPRIYA · BSE: 543434 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹896.65
Market cap: ₹7,216 Cr
Revenue (annual): ₹827.9 Cr
Net profit (annual): ₹209.1 Cr
P/E (TTM): 36.4×Sector 47.4×
Promoter holding: 68.30%+0.00% QoQ
FII holding: 6.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Annual General Meeting 5 Other Announcement 3 Legal & Regulatory 3 Financial Results 3 Results Update 2 Dividend 2 Board Meeting Date 2 Results Correction 1 Regulatory Approval 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 Apr 2026 11:48 IST BSE

Regulatory ApprovalAlfa Alert

Supriya Lifescience Regulatory Approval

Supriya Lifescience Ltd successfully completed a USFDA inspection at its Lote manufacturing facility. The inspection, conducted in February 2026, concluded with one minor observation and the receipt of an Establishment Inspection Report (EIR) indicating Voluntary Action Indicated (VAI) status. This confirms the facility's compliance with current Good Manufacturing Practice (cGMP) standards.

Read the filing ↗